Skip to content

Impact of CO2 on Cerebral Blood Flow in Infants Less Than 6 Months During General Anaesthesia

Impact of CO2 on Cerebral Blood Flow in Infants Less Than 6 Months During General Anaesthesia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03567031
Enrollment
60
Registered
2018-06-25
Start date
2017-11-27
Completion date
2019-03-03
Last updated
2019-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, General, Infant

Keywords

Pediatric Anesthesia, Near-Infrared Spectroscopy, End-Tidal CO2, Cerebral Blood Flow

Brief summary

The study aims at assessing cerebral blood flow variations following expired CO2 variations in anaesthetized infants less than 6 months, during a routine general anesthesia.

Detailed description

The study aims at assessing cerebral blood flow (measured with Near-Infrared Reflectance Spectroscopy - NIRS - and transcranial Doppler - DTC) variations following end-tidal expired CO2 variations in anaesthetized infants less than 6 months, during a routine general anesthesia performed according to standards of care.

Interventions

PROCEDUREEtCO2 modification

Controlled modification of EtCO2 through modification of ventilation parameters under general anesthesia without spontaneous breathing

Sponsors

St. Justine's Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Masking description

Patient is under general anesthesia

Intervention model description

Cerebral blood flow is measured in each patient at 3 different, controlled levels of end-tidal CO2

Eligibility

Sex/Gender
ALL
Age
No minimum to 6 Months
Healthy volunteers
Yes

Inclusion criteria

* Age \< or = 6 months * ASA class \< or = 3 * General anesthesia required for surgery

Exclusion criteria

* No parental consent * Emergency surgery * Preexisting neurological condition * Hemodynamic instability * Preexisting hypoxemia and/or hypercapnia * Laparoscopy or thoracoscopy, if expected EtCO2 level achieving would require unsafe ventilation parameters

Design outcomes

Primary

MeasureTime frameDescription
NIRS variation5 to 10 minutesNear-Infrared Spectroscopy value variation after EtCO2 modification

Secondary

MeasureTime frameDescription
DTC variation5 to 10 minutesTranscranial Doppler values variation after EtCO2 modification

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026